Compare stocks

Xlife Sciences AG is a Swiss-based company focused on developing and advancing healthcare and life sciences technologies. It operates primarily in the biotechnology and medical technology sectors, concentrating on early-stage life science projects with significant potential in pharmaceuticals, medical devices, diagnostics, and digital health solutions. The company collaborates with research institutions and industry experts to foster innovation and accelerate the commercialization of health-related technologies. Headquartered in Zurich, Switzerland, Xlife Sciences leverages a strategic geographic location to engage with European research hubs and industry partners. The company's unique approach involves investing in and nurturing a diverse portfolio of projects to diversify risk and maximize value creation.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.